Sort
30,917 grants matching “tumor microenvironment”
Novel Energy Restriction-Mimetic Agents for Prostate Cancer Prevention
$277,014Ching-Shih Chen · Ohio State University · R01 · FY2014 · CA
Arginase Production in Cancer: Evading Immune Response
$276,975Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2013 · CA
The Role of Ubiquitin-Proteasome Pathway in Myeloma Bone Disease
$276,968Babatunde Olukayode Oyajobi · Vanderbilt University · P01 · FY2007 · CA
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
$276,937Xin Li · New York University · R01 · FY2015 · CA
Project 5: Microenvironment manipulation using anti-angiogenics to improve immunotherapy in melanoma
$276,920Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Correction of dendritic cells defects in cancer
$276,841Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Correction of dendritic cells defects in cancer
$276,841Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Regulation of Metastatic Development by Heritable Variants in the Tumor Microenvironment
$276,729Paula Jill Hurley · Vanderbilt University Medical Center · R01 · FY2023 · CA
Animal Imaging
$276,716Carl Lekaye · Sloan-Kettering Inst Can Research · P30 · FY2017 · CA
Peptide-amphiphile biomimetics for targeted therapies
$276,675Gregg B Fields · University Of Texas Hlth Science Center · R01 · FY2008 · EB
Promotion of angiogenesis in lung cancer by MIF
$276,601Douglas A Arenberg · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Promotion of angiogenesis in lung cancer by MIF
$276,601Douglas A Arenberg · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction
$276,569Hannah Rabinowich · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · CA
Overcoming Immune Checkpoint Blockade Resistance in Glioblastoma with a Novel Stem Cell Biotherapeutic
$276,544Edgardo Rodriguez · Ioncologi Inc · R42 · FY2025 · CA
The role of PPARd-controlled CIITA/MHCII expression in Treg's function in tumor immunity
$276,450Ye Zheng · Salk Institute For Biological Studies · R21 · FY2025 · AI
Molecular Imaging of Delivery Cells (Neural Precursor and T Lymphocytes) and Targ
$276,446Ralph Weissleder · Massachusetts General Hospital · P01 · FY2009 · CA
Collaborative Research: Microengineered Tumor-Mimetic Collagen Landscapes to Test the Role of Prognostic Structural Cues on Cell Migration Through the Extracellular Matrix
$276,437Edward Brown · University Of Rochester · · FY2022 · ENG
Prostacyclin and Peroxisome Proliferator-Activated Receptor-Gamma in Lung Cancer
$276,434Raphael A. Nemenoff · University Of Colorado Denver · P50 · FY2015 · CA
Integrative Cancer Scholars Training Grant
$276,400Anne Elizabeth Cress · University Of Arizona · T32 · FY2020 · CA
Tageting BAFF and BAFF-Induced Non-Canonical NF-kB Pathways for Enhancing Mantle
$276,390Jianguo Tao · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
$276,360Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA
Core 2: Theory Core - Multiscale models for mechano-chemical phenomena
$276,356Andrea Liu · University Of Pennsylvania · U54 · FY2017 · CA
DEFINITION OF MICROENVIRONMENT IN BREAST CANCER
$276,344University Of Calif-Lawrenc Berkeley Lab · R01 · FY2002 · CA
Project 1 - Mitochondrial reprogramming in prostate cancer metastasis
$276,329Dario C. Altieri · Wistar Institute · P01 · FY2017 · CA
Molecular and Cellular Mechanisms of Tumor Development
$276,264Caroline Margaret Alexander · University Of Wisconsin-Madison · T32 · FY2015 · CA